Literature DB >> 7480463

Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia.

J L Waddington1, H A Youssef, A Kinsella.   

Abstract

Current clinical correlates of duration of initially untreated psychotic symptoms were investigated in a cross-sectional analysis followed by a 10-year prospective study among 88 in-patients with a long-standing schizophrenic illness, many of whom had experienced prolonged periods of untreated psychosis due to illness onset and hospital admission in the pre-neuroleptic era. After controlling for the effects of age, and duration and continuity of subsequent neuroleptic treatment, the primary clinical correlate of duration of initially untreated psychosis was muteness. Over the subsequent 10-year-period, no new cases of muteness emerged and some existing cases of muteness partially resolved, though the speech that emerged remained very sparse and revealed generally gross cognitive debility. The pathophysiology underlying active, unchecked psychosis may also constitute an active morbid process that is associated with the further progression of severe negative symptoms and cognitive dysfunction in the long-term.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480463     DOI: 10.1017/s0033291700035108

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  8 in total

Review 1.  Improving outcome in schizophrenia: the case for early intervention.

Authors:  A K Malla; R M Norman; L P Voruganti
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

Review 2.  The effects of early and sustained intervention on the long-term morbidity of schizophrenia.

Authors:  R J Wyatt; I D Henter
Journal:  J Psychiatr Res       Date:  1998 May-Aug       Impact factor: 4.791

3.  Family-level predictors and correlates of the duration of untreated psychosis in African American first-episode patients.

Authors:  Michael T Compton; Sandra M Goulding; Tynessa L Gordon; Paul S Weiss; Nadine J Kaslow
Journal:  Schizophr Res       Date:  2009-10-14       Impact factor: 4.939

4.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

5.  Electroconvulsive Therapy for Long-term Mutism in a Case of Noncatatonic Paranoid Schizophrenia.

Authors:  Aniruddha Basu; Priti Singh; Rajiv Gupta; Savita Kundu
Journal:  Innov Clin Neurosci       Date:  2013-07

6.  Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia.

Authors:  Robin M Murray; Colm McDonald; Elvira Bramon
Journal:  World Psychiatry       Date:  2002-10       Impact factor: 49.548

7.  The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.

Authors:  Danuta M Lisiecka; John Suckling; Thomas R E Barnes; Imran B Chaudhry; Paola Dazzan; Nusrat Husain; Peter B Jones; Eileen M Joyce; Stephen M Lawrie; Rachel Upthegrove; Bill Deakin
Journal:  Trials       Date:  2015-03-02       Impact factor: 2.279

8.  Effect of an education program on improving help-seeking among parents of junior and senior high school students in Japan.

Authors:  Hatsumi Yoshii; Yuichiro Watanabe; Hideaki Kitamura; Zhang Nan; Kouhei Akazawa
Journal:  Glob J Health Sci       Date:  2011-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.